查詢結果分析
相關文獻
- Cytogenic and Molecular Analyses of 46,XX Male Syndrome with Clinical Comparison to Other Groups with Testicular Azoospermia of Genetic Origin
- Study of Human Y Chromosome Polymorphism in Taiwan
- Microscopic Gonadoblastoma in a Patient with 46,XY Gonadal Dysgenesis
- 單一副睪丸精子顯微注射術:對於阻塞性無精症所引起的男性不孕症的革命性人工生殖技術療法
- Population Genetic Study of Selected Tetranucleotide Repeat DNA Polymorphisms on Chromosomes Y and 12
- Detection of Y-Chromosome Sequences in Patients with X-Chromosome Abnormalities
- Detection of Y-Chromosomal DNA with Marker Chromosomes in Turner's Syndrome
- 以Y染色體特定DNA探針鑑定胎兒性別研究
- 基因體科學(1)--令人拍案驚奇的人類Y染色體:看Y染色體如何力抗演化逆流
- 人類性別染色體--Y
第1筆 /總和 1 筆
/ 1 筆
頁籤選單縮合
題名 | Cytogenic and Molecular Analyses of 46,XX Male Syndrome with Clinical Comparison to Other Groups with Testicular Azoospermia of Genetic Origin |
---|---|
作者 | Chiang, Han-sun; Wu, Yi-no; Wu, Chien-chih; Hwang, Jiann-loung; | 書刊名 | Journal of the Formosan Medical Association |
卷期 | 112:2 2013.02[民102.02] |
頁次 | 頁72-78 |
分類號 | 415.87 |
關鍵詞 | Y染色體; 無精症; 46,XX male syndrome; Testicular azoospermia; Y chromosome; |
語文 | 英文(English) |
英文摘要 | Background/Purpose: XX male is a rare sex chromosomal disorder in infertile men. The purpose of this study was to distinguish the clinical and genetic features of the 46,XX male syndrome from other more frequent, testicular-origin azoospermic causes of male infertility. Methods: To study 46,XX male syndrome, we compared clinical and endocrinological parameters to other groups with testicular-origin azoospermia, and to an age-matched group of healthy males and females as normal control. Fluorescent in situ hybridization for detection and localization of the sex-determining region of the Y gene (SRY), array-based comparative genomic hybridization screening, and real-time qualitative polymerase chain reaction of FGF9, WT1, NR5A1, and SPRY2 genes were performed in this genetic investigation. Results: Our three patients with 46,XX male syndrome had a much higher follicular-stimulating hormone level, lower body height, lower testosterone level, and ambiguous external genitalia. One of the three patients with 46,XX male syndrome was SRY-negative. A further genetic study, including a comparative genomic hybridization array and real-time polymerase chain reaction, showed a gain of FGF9 copy numbers only in the SRY-negative 46,XX male. The genetic copy number of the FGF9 gene was duplicated in that case compared to the normal female control and was significantly lower than that of the normal male control. No such genomic gain was observed in the case of the two SRY-positive 46,XX males. Conclusion: Similar to clinical manifestations of 46,XX male syndrome, genetic evidence in this study suggests that FGF9 may contribute to sex reversal, but additional confirmation with more cases is still needed. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。